<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019f13c9-f48e-7aa6-949e-70339bd0aa35,g:c0c3eb3d-7ce2-4cd0-b60b-2aac38d7cacf-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:inhibrx="http://inhibrx.namespace.com/20260630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://inhibrx.namespace.com/20260630">
  <xs:import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2026" schemaLocation="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="inhibrx-20260630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="inhibrx-20260630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="inhibrx-20260630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="inhibrx-20260630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://inhibrx.namespace.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://inhibrx.namespace.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://inhibrx.namespace.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://inhibrx.namespace.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>9952153 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityDeficit" roleURI="http://inhibrx.namespace.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit">
        <link:definition>9952154 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://inhibrx.namespace.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>9952155 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://inhibrx.namespace.com/role/ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>9952156 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERFINANCIALINFORMATION" roleURI="http://inhibrx.namespace.com/role/OTHERFINANCIALINFORMATION">
        <link:definition>9952157 - Disclosure - OTHER FINANCIAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://inhibrx.namespace.com/role/DEBT">
        <link:definition>9952158 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYDEFICIT" roleURI="http://inhibrx.namespace.com/role/STOCKHOLDERSEQUITYDEFICIT">
        <link:definition>9952159 - Disclosure - STOCKHOLDERS&#8217; EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYCOMPENSATIONPLAN" roleURI="http://inhibrx.namespace.com/role/EQUITYCOMPENSATIONPLAN">
        <link:definition>9952160 - Disclosure - EQUITY COMPENSATION PLAN</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LICENSEREVENUES" roleURI="http://inhibrx.namespace.com/role/LICENSEREVENUES">
        <link:definition>9952161 - Disclosure - LICENSE REVENUES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://inhibrx.namespace.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>9952162 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://inhibrx.namespace.com/role/SUBSEQUENTEVENTS">
        <link:definition>9952163 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://inhibrx.namespace.com/role/ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>9955511 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://inhibrx.namespace.com/role/ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>9955512 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERFINANCIALINFORMATIONTables" roleURI="http://inhibrx.namespace.com/role/OTHERFINANCIALINFORMATIONTables">
        <link:definition>9955513 - Disclosure - OTHER FINANCIAL INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://inhibrx.namespace.com/role/DEBTTables">
        <link:definition>9955514 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYDEFICITTables" roleURI="http://inhibrx.namespace.com/role/STOCKHOLDERSEQUITYDEFICITTables">
        <link:definition>9955515 - Disclosure - STOCKHOLDERS&#8217; EQUITY (DEFICIT) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYCOMPENSATIONPLANTables" roleURI="http://inhibrx.namespace.com/role/EQUITYCOMPENSATIONPLANTables">
        <link:definition>9955516 - Disclosure - EQUITY COMPENSATION PLAN (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LICENSEREVENUESTables" roleURI="http://inhibrx.namespace.com/role/LICENSEREVENUESTables">
        <link:definition>9955517 - Disclosure - LICENSE REVENUES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESTables" roleURI="http://inhibrx.namespace.com/role/COMMITMENTSANDCONTINGENCIESTables">
        <link:definition>9955518 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://inhibrx.namespace.com/role/ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
        <link:definition>9955519 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueMeasurementsonaRecurringBasisDetails" roleURI="http://inhibrx.namespace.com/role/ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueMeasurementsonaRecurringBasisDetails">
        <link:definition>9955520 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value Measurements on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPotentialDilutiveSecuritiesExcludedfromDilutedLossPerShareDetails" roleURI="http://inhibrx.namespace.com/role/ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPotentialDilutiveSecuritiesExcludedfromDilutedLossPerShareDetails">
        <link:definition>9955521 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Potential Dilutive Securities Excluded from Diluted Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofSignificantExpenseCategoriesDetails" roleURI="http://inhibrx.namespace.com/role/ORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofSignificantExpenseCategoriesDetails">
        <link:definition>9955522 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Significant Expense Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERFINANCIALINFORMATIONScheduleofPrepaidExpenseandOtherCurrentAssetsDetails" roleURI="http://inhibrx.namespace.com/role/OTHERFINANCIALINFORMATIONScheduleofPrepaidExpenseandOtherCurrentAssetsDetails">
        <link:definition>9955523 - Disclosure - OTHER FINANCIAL INFORMATION - Schedule of Prepaid Expense and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERFINANCIALINFORMATIONScheduleofPropertyandEquipmentNetDetails" roleURI="http://inhibrx.namespace.com/role/OTHERFINANCIALINFORMATIONScheduleofPropertyandEquipmentNetDetails">
        <link:definition>9955524 - Disclosure - OTHER FINANCIAL INFORMATION - Schedule of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERFINANCIALINFORMATIONScheduleofDepreciationandAmortizationExpenseDetails" roleURI="http://inhibrx.namespace.com/role/OTHERFINANCIALINFORMATIONScheduleofDepreciationandAmortizationExpenseDetails">
        <link:definition>9955525 - Disclosure - OTHER FINANCIAL INFORMATION - Schedule of Depreciation and Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERFINANCIALINFORMATIONScheduleofDepreciationandAmortizationExpenseDetails_1" roleURI="http://inhibrx.namespace.com/role/OTHERFINANCIALINFORMATIONScheduleofDepreciationandAmortizationExpenseDetails_1">
        <link:definition>9955525 - Disclosure - OTHER FINANCIAL INFORMATION - Schedule of Depreciation and Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERFINANCIALINFORMATIONScheduleofAccruedExpensesDetails" roleURI="http://inhibrx.namespace.com/role/OTHERFINANCIALINFORMATIONScheduleofAccruedExpensesDetails">
        <link:definition>9955526 - Disclosure - OTHER FINANCIAL INFORMATION - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNarrativeDetails" roleURI="http://inhibrx.namespace.com/role/DEBTNarrativeDetails">
        <link:definition>9955527 - Disclosure - DEBT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofLongTermDebtDetails" roleURI="http://inhibrx.namespace.com/role/DEBTScheduleofLongTermDebtDetails">
        <link:definition>9955528 - Disclosure - DEBT - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofMaturitiesofLongTermDebtDetails" roleURI="http://inhibrx.namespace.com/role/DEBTScheduleofMaturitiesofLongTermDebtDetails">
        <link:definition>9955529 - Disclosure - DEBT - Schedule of Maturities of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYDEFICITNarrativeDetails" roleURI="http://inhibrx.namespace.com/role/STOCKHOLDERSEQUITYDEFICITNarrativeDetails">
        <link:definition>9955530 - Disclosure - STOCKHOLDERS&#8217; EQUITY (DEFICIT) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYDEFICITScheduleofCommonStockReservedforFutureIssuanceDetails" roleURI="http://inhibrx.namespace.com/role/STOCKHOLDERSEQUITYDEFICITScheduleofCommonStockReservedforFutureIssuanceDetails">
        <link:definition>9955531 - Disclosure - STOCKHOLDERS&#8217; EQUITY (DEFICIT) - Schedule of Common Stock Reserved for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYCOMPENSATIONPLANNarrativeDetails" roleURI="http://inhibrx.namespace.com/role/EQUITYCOMPENSATIONPLANNarrativeDetails">
        <link:definition>9955532 - Disclosure - EQUITY COMPENSATION PLAN - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYCOMPENSATIONPLANScheduleofStockOptionsActivityDetails" roleURI="http://inhibrx.namespace.com/role/EQUITYCOMPENSATIONPLANScheduleofStockOptionsActivityDetails">
        <link:definition>9955533 - Disclosure - EQUITY COMPENSATION PLAN - Schedule of Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYCOMPENSATIONPLANScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueDetails" roleURI="http://inhibrx.namespace.com/role/EQUITYCOMPENSATIONPLANScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueDetails">
        <link:definition>9955534 - Disclosure - EQUITY COMPENSATION PLAN - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYCOMPENSATIONPLANScheduleofStockBasedCompensationExpenseDetails" roleURI="http://inhibrx.namespace.com/role/EQUITYCOMPENSATIONPLANScheduleofStockBasedCompensationExpenseDetails">
        <link:definition>9955535 - Disclosure - EQUITY COMPENSATION PLAN - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYCOMPENSATIONPLANScheduleofStockBasedCompensationExpenseDetails_1" roleURI="http://inhibrx.namespace.com/role/EQUITYCOMPENSATIONPLANScheduleofStockBasedCompensationExpenseDetails_1">
        <link:definition>9955535 - Disclosure - EQUITY COMPENSATION PLAN - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LICENSEREVENUESScheduleofLicenseandGrantRevenueDetails" roleURI="http://inhibrx.namespace.com/role/LICENSEREVENUESScheduleofLicenseandGrantRevenueDetails">
        <link:definition>9955536 - Disclosure - LICENSE REVENUES - Schedule of License and Grant Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LICENSEREVENUESNarrativeDetails" roleURI="http://inhibrx.namespace.com/role/LICENSEREVENUESNarrativeDetails">
        <link:definition>9955537 - Disclosure - LICENSE REVENUES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESNarrativeDetails" roleURI="http://inhibrx.namespace.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails">
        <link:definition>9955538 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESScheduleofOperatingLeaseLiabilityMaturityDetails" roleURI="http://inhibrx.namespace.com/role/COMMITMENTSANDCONTINGENCIESScheduleofOperatingLeaseLiabilityMaturityDetails">
        <link:definition>9955539 - Disclosure - COMMITMENTS AND CONTINGENCIES - Schedule of Operating Lease Liability Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESScheduleofOperatingLeaseLiabilityMaturityDetails_1" roleURI="http://inhibrx.namespace.com/role/COMMITMENTSANDCONTINGENCIESScheduleofOperatingLeaseLiabilityMaturityDetails_1">
        <link:definition>9955539 - Disclosure - COMMITMENTS AND CONTINGENCIES - Schedule of Operating Lease Liability Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetails" roleURI="http://inhibrx.namespace.com/role/SUBSEQUENTEVENTSDetails">
        <link:definition>9955540 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="inhibrx_InterestIncomeNonoperating" abstract="false" name="InterestIncomeNonoperating" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_NoncashOperatingLeaseExpense" abstract="false" name="NoncashOperatingLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_PaymentsOfDebtIssuanceCostsSecuredDebt" abstract="false" name="PaymentsOfDebtIssuanceCostsSecuredDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_OtherNoncashInvestingAndFinancingItemsWarrantLiabilitiesIncurred" abstract="false" name="OtherNoncashInvestingAndFinancingItemsWarrantLiabilitiesIncurred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_CollaborativeArrangementAndArrangementOtherThanCollaborativeAbstract" abstract="true" name="CollaborativeArrangementAndArrangementOtherThanCollaborativeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="inhibrx_LicenseAndGrantRevenueTextBlock" abstract="false" name="LicenseAndGrantRevenueTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="inhibrx_LiquidityPolicyTextBlock" abstract="false" name="LiquidityPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="inhibrx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" abstract="false" name="ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="inhibrx_ScheduleOfLicenseAndGrantRevenueTableTextBlock" abstract="false" name="ScheduleOfLicenseAndGrantRevenueTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="inhibrx_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="inhibrx_ResearchAndDevelopmentExpensePersonnel" abstract="false" name="ResearchAndDevelopmentExpensePersonnel" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_ResearchAndDevelopmentExpenseClinicalTrials" abstract="false" name="ResearchAndDevelopmentExpenseClinicalTrials" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_ResearchAndDevelopmentExpenseContractManufacturing" abstract="false" name="ResearchAndDevelopmentExpenseContractManufacturing" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_ResearchAndDevelopmentExpenseEquipmentDepreciationAndFacility" abstract="false" name="ResearchAndDevelopmentExpenseEquipmentDepreciationAndFacility" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_GeneralAndAdministrativeExpensePersonnel" abstract="false" name="GeneralAndAdministrativeExpensePersonnel" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_ClinicalTrailsPrepaidExpenseCurrent" abstract="false" name="ClinicalTrailsPrepaidExpenseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_ClinicalDrugSubstanceAndProductManufacturingPrepaidExpenseCurrent" abstract="false" name="ClinicalDrugSubstanceAndProductManufacturingPrepaidExpenseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_SoftwareLicensePrepaidCurrent" abstract="false" name="SoftwareLicensePrepaidCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_ProfessionalFeesCurrent" abstract="false" name="ProfessionalFeesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_OutsideResearchAndDevelopmentServicesPrepaidExpenseCurrent" abstract="false" name="OutsideResearchAndDevelopmentServicesPrepaidExpenseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_AccruedClinicalTrialsCurrent" abstract="false" name="AccruedClinicalTrialsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_AccruedClinicalDrugSubstanceAndProductManufacturingCurrent" abstract="false" name="AccruedClinicalDrugSubstanceAndProductManufacturingCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_AccruedInterestExpenseCurrent" abstract="false" name="AccruedInterestExpenseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_AccruedOutsideResearchAndDevelopmentOtherCurrent" abstract="false" name="AccruedOutsideResearchAndDevelopmentOtherCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_OxfordTermLoansMember" abstract="true" name="OxfordTermLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="inhibrx_OxfordWarrants2025Member" abstract="true" name="OxfordWarrants2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="inhibrx_OxfordWarrants2026Member" abstract="true" name="OxfordWarrants2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="inhibrx_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_DebtInstrumentPrincipalAndInterestTerm" abstract="false" name="DebtInstrumentPrincipalAndInterestTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="inhibrx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercent" abstract="false" name="DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="inhibrx_DebtInstrumentPrepaymentFee" abstract="false" name="DebtInstrumentPrepaymentFee" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="inhibrx_LongTermDebtLiquidityThreshold" abstract="false" name="LongTermDebtLiquidityThreshold" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_TermLoanAMember" abstract="true" name="TermLoanAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="inhibrx_TermLoanBMember" abstract="true" name="TermLoanBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="inhibrx_LongTermDebtMaturityAfterYearThree" abstract="false" name="LongTermDebtMaturityAfterYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_WarrantsPreFundedMember" abstract="true" name="WarrantsPreFundedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="inhibrx_ClassOfWarrantOrRightPurchasePriceOfWarrantsOrRights1" abstract="false" name="ClassOfWarrantOrRightPurchasePriceOfWarrantsOrRights1" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="inhibrx_PreFundedWarrantsMember" abstract="true" name="PreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="inhibrx_A2024PlanMember" abstract="true" name="A2024PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="inhibrx_LicenseNonAffiliateMember" abstract="true" name="LicenseNonAffiliateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="inhibrx_ScitheraInc.Member" abstract="true" name="ScitheraInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="inhibrx_CollaborativeArrangementNonrefundablePayment" abstract="false" name="CollaborativeArrangementNonrefundablePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_MaximumPotentialMilestonePayments" abstract="false" name="MaximumPotentialMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_RevenueFromContractWithCustomerExcludingAssessedTaxNumberOfPerformanceObligation" abstract="false" name="RevenueFromContractWithCustomerExcludingAssessedTaxNumberOfPerformanceObligation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="inhibrx_OperatingLeasePaymentsIncludedInMeasurementOfLeaseLiability" abstract="false" name="OperatingLeasePaymentsIncludedInMeasurementOfLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_LineOfCreditFacilityMaximumBorrowingCapacityFundedUponExecutionOfTheAmendment" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityFundedUponExecutionOfTheAmendment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="inhibrx_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalFunds" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityAdditionalFunds" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
